Delay of Early B-Lymphocyte Development by Gamma 2b Immunoglobulin Transgene
Author Information
Author(s): KATHLEEN A. DENIS, SCOTT PROVOST, OWEN N. WITTE, RALPH L. BRINSTER, URSULA STORB
Primary Institution: Howard Hughes Medical Institute, UCLA
Hypothesis
The presence of a gamma 2b immunoglobulin transgene affects early B-lymphocyte development.
Conclusion
The gamma 2b transgene delays the expression of endogenous mu immunoglobulin in B-lymphocyte development.
Supporting Evidence
- Transgenic mice showed a significant reduction in pre-B-cell populations compared to normal mice.
- Delayed expression of endogenous mu Ig was observed in lymphoid bone marrow cultures from transgenic mice.
- Transgenic mice had reduced levels of BP-1 expression, indicating altered B-lymphocyte differentiation.
Takeaway
Mice with a special gene that makes a type of antibody have trouble developing certain immune cells, which means they can't make antibodies as quickly as normal mice.
Methodology
The study involved examining transgenic mice for changes in B-cell differentiation and Ig gene rearrangement using flow cytometry and lymphoid bone marrow cultures.
Limitations
The study primarily focuses on early B-lymphocyte development and may not fully capture later stages or other immune responses.
Participant Demographics
Transgenic mice and their normal littermates were used in the study.
Want to read the original?
Access the complete publication on the publisher's website